PJP

Invesco Dynamic Pharmaceuticals ETF

Up$67.41
+$0.85
(+1.28%)
As of 1:00:00 AM EDT | 2/15/19  |  Market Closed

PJP Trading Data

Open

$66.9

Low Price

$66.84

High Price

$67.41

Previous Last Price

$66.56

Bid Size

$0 X 0

Ask Size

$0 X 0

PJP Portfolio Data

AUM

$467,767,500

Shares

7,050

PE Ratio

15.53

Price / Book Ratio

3.91

Expense Ratio

0.57

Net Asset Value

$66.35

Volume

Volume

16,700

Avg. Volume (YDT)

31,516

Dollar Volume

$918,382

Weekly Avg. Volume

20,980

Monthly Avg. Volume

34,650

Quarterly Avg. Volume

35,567

PJP Fund Description

The Invesco Dynamic Pharmaceuticals ETF is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

PJP Chart

PJP Summary

Fund Family

Invesco

Tracks This Index

Invesco Dynamic Pharmaceuticals ETF

Inception Date

2005-06-23

Asset Class

Equity

Asset Class Size

Biotech

PJP Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

PJP Holdings

Top 10 Holdings

Eli Lilly & Co (LLY)
5.34%
Merck & Co Inc (MRK)
5.24%
Abbott Laboratories (ABT)
5.22%
Gilead Sciences Inc (GILD)
4.93%
Amgen Inc (AMGN)
4.77%
Pfizer Inc (PFE)
4.77%
Johnson & Johnson (JNJ)
4.76%
AbbVie Inc (ABBV)
4.63%
Celgene Corp (CELG)
3.65%
Enanta Pharmaceuticals Inc (ENTA)
3.31%

Total PJP Holdings

Total Holdings: 31

Eli Lilly & Co (LLY)
5.34%
Merck & Co Inc (MRK)
5.24%
Abbott Laboratories (ABT)
5.22%
Gilead Sciences Inc (GILD)
4.93%
Amgen Inc (AMGN)
4.77%
Pfizer Inc (PFE)
4.77%
Johnson & Johnson (JNJ)
4.76%
AbbVie Inc (ABBV)
4.63%
Celgene Corp (CELG)
3.65%
Enanta Pharmaceuticals Inc (ENTA)
3.31%
Amphastar Pharmaceuticals Inc (AMPH)
3.31%
Regeneron Pharmaceuticals Inc (REGN)
3.26%
Taro Pharmaceutical Industries Ltd (TARO)
3.22%
Horizon Pharma Plc (HZNP)
3.17%
Bausch Health Cos Inc (BHC)
3.03%
Alexion Pharmaceuticals Inc (ALXN)
2.88%
United Therapeutics Corp (UTHR)
2.85%
Biogen Inc (BIIB)
2.81%
Bristol-Myers Squibb Co (BMY)
2.76%
Mylan NV (MYL)
2.61%
Emergent BioSolutions Inc (EBS)
2.56%
Allergan PLC (AGN)
2.52%
Endo International PLC (ENDP)
2.44%
Supernus Pharmaceuticals Inc (SUPN)
2.41%
Jazz Pharmaceuticals PLC (JAZZ)
2.39%
Innoviva Inc (INVA)
2.34%
Pacira Pharmaceuticals Inc/DE (PCRX)
2.33%
Corcept Therapeutics Inc (CORT)
2.27%
Acorda Therapeutics Inc (ACOR)
2.18%
Ligand Pharmaceuticals Inc (LGND)
2.07%
PowerShares Dynamic Pharmaceuticals Portfolio (PJP)
0%

PJP Technicals

Alpha

-7.2

Beta

1.15

Leverage

Long

Standard Deviation

3.97

PJP Dividends

Dividend Date

2018-12-24

Latest Dividend

0.364

Annual Dividend

0.69

Annual Dividend Rate

0.69

Annual Dividend Yield

1.05

PJP Performance

YTD Return

8.12%

1 Year Return

1.35%

3 Year Return

12.41%

5 Year Return

13.48%

10 Year Return

397.86%

PJP Related Articles